课题基金 / 基金详情

CARDIOVIRAL POLY(C) TRACTS AND VIRUS PATHOGENICITY

CARDIOVIRAL POLY(C) TRACTS AND VIRUS PATHOGENICITY
心肌多聚(C)病毒束和病毒致病性
批准号:
3145609
负责人:
ANN C. PALMENBERG
金额:
$15.65万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-01-01 至 1995-12-31

项目摘要

项目成果

ANN C. PALMENBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A series of cDNA plasmids containing full-length copies of Mengovirus and MengoEMC (encephalomyocarditis) virus chimeric genomes have been developed and characterized. The isolates differ from each other and from the wildtype Mengo and EMC virus sequences only in the lengths of their 5' non- coding poly(C) tracts. RNA transcripts derived from these constructions are completely infectious to HeLa cells and the resulting genetically engineered progeny viruses. However, upon inoculation of mice, the natural host for cardioviruses, the engineered viruses carrying shortened versions of the poly(C) tract (eg: C8, C12 or C13UC10) exhibit dramatically attenuated pathogenicity relative to the original wildtype viruses or relative to a newly engineered progeny virus with a wildtype-Mengo length poly(C) tract (C50UC10). The attenuation is manifest in a 106-1010 fold increase in the virus LD50. Moreover, animals receiving sublethal doses from any of the short poly(C) strains characteristically develop high level of neutralizing antibodies and acquired lifelong protective immunity against (lethal) challenge with wildtype virus. It is the goal of this proposal to explore and characterize the molecular basis for poly(C)- mediated attenuation with the eventual objective of exploiting this phenomena and the principles to be learned from it, for the development of new and effective, live picornavirus vaccines. The specific aims are: (1) To genetically engineer a spectrum of full-length cardiovirus plasmids containing altered poly(c) tracts, discontinuities, viral chimeric sequences, rearrangements and other variations within the 5' non-coding regions; (2) To test the relative effects of such constructions on transcript infectivity and progeny virus viability in several relevant tissue culture cell lines; (3) To assess the pathogenic effects of infectious genetically engineered progeny viruses in mice, in order to evaluate the host protective responses, viral etiology, replication, clearance and sequence reversion potential; (4) To formulate and test hypotheses to explain at the molecular level, the role of picornaviral 5' non-coding sequences, and in particular poly(C) tracts, in the restrictive determination of virus-host interactions. The potential role of cytokine induction as a contributing element to the enhancement of wildtype viral infections will be examined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying Coronavirus B-cell Epitopes Associated with COVID-19 Illness Severity
  • 批准号:
    10201317
  • 项目类别:
  • 资助金额:
    $40.6万
  • 财政年份:
    2020
  • 负责人:
    ANN C. PALMENBERG
  • 依托单位:
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
  • 批准号:
    10327681
  • 项目类别:
  • 资助金额:
    $40.35万
  • 财政年份:
    2020
  • 负责人:
    ANN C. PALMENBERG
  • 依托单位:
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
  • 批准号:
    10440067
  • 项目类别:
  • 资助金额:
    $33.22万
  • 财政年份:
    2013
  • 负责人:
    ANN C. PALMENBERG
  • 依托单位:
COMPARATIVE MOLECULAR BIOLOGY AND GENOME STRUCTURE OF HRV-C
  • 批准号:
    8469998
  • 项目类别:
  • 资助金额:
    $21.38万
  • 财政年份:
    2013
  • 负责人:
    ANN C. PALMENBERG
  • 依托单位:
海外基金